We performed a 12-month single-center pilot randomized , controlled trial of 50,000 IU/week of cholecalciferol ( D3 ) versus no supplementation in 96 hemodialysis patients with serum 25 ( OH ) D < 25 ng/mL , measuring effects on serum 25 ( OH ) D and phenotypic and functional properties of T-cells .